44 Sessions  PREVNEXT

  • Main Hall
    1F
  • Sakura
    1F
  • Annex 1
    1F
  • Annex 2
    1F
  • Room A
    2F
  • Room B1
    2F
  • Room B2
    2F
  • Room C1
    1F
  • Room C2
    1F
  • Room D
    1F
  • Room E
    1F
8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 21:00 22:00

11:15

KarlDeisseroth{DEISSEROTHKARL}____Plenary Lecture 2
Linking real-time activity with detailed anatomy at cellular resolution across the vertebrate brain|1|2|MasayoshiMishina{MISHINAMASAYOSHI}____

S03

Plenary Lecture 2
Linking real-time ac...

17:00

FengZhang{ZHANGFENG}____Tang Prize Lecture
ADVANCES IN GENOME EDITING TECHNOLOGIES|1|1|YunYen{YENYUN}____

S06

Tang Prize Lecture
ADVANCES IN GENOME ...

08:30

WilliamA.Catterall{CATTERALLWILLIAMA.}____Cutting Edge Lecture 10
Voltage-Gated Sodium and Calcium Channels at Atomic Resolution: Structure, Function, and Pharmacology|1|3|HaruhikoBito{BITOHARUHIKO}____

S18

Cutting Edge Lecture 10
Volt...

08:30

JohnA.Hartley{HARTLEYJOHNA.}____Cutting Edge Lecture 11
The emerging role and challenges of antibody-drug conjugates (ADCs) in the treatment of cancer and other diseases|1|14|AtsushiOhtsu{OHTSUATSUSHI}____

S19

Cutting Edge Lecture 11
The ...

08:30

SimonMaxwell{MAXWELLSIMON}____Cutting Edge Lecture 12
Prescribing safety assessment: Ensuring competency of new doctors to use medicines|1|11|ShinichiroUeda{UEDASHINICHIRO}____

S20

Cutting Edge Lecture 12
Pres...

08:30

MakotoAihara{AIHARAMAKOTO}____Cutting Edge Lecture 13
Lipid mediators regulating intraocular pressure and therapeutic target for glaucoma|1|15|HideakiHara{HARAHIDEAKI}____

S21

Cutting Edge Lecture 13
Lipi...

08:30

ChristiaanB.Brink{BRINKCHRISTIAANB.}____Cutting Edge Lecture 14
Pharmacology for Africa Prestigious Lecture - Ethics and cutting-edge pre-clinical research: An African perspective|1|1|DouglasW.Oliver{OLIVERDOUGLASW.}____

S22

Cutting Edge Lecture 14
Phar...

08:30

DonaldE.Mager{MAGERDONALDE.}____Cutting Edge Lecture 15
Future of Pharmacometrics|1|16|YujiKumagai{KUMAGAIYUJI}____

S23

Cutting Edge Lecture 15
Futu...

08:30

AshleyJ.Stevens{STEVENSASHLEYJ.}____Cutting Edge Lecture 16
The Role of Public Sector Research in the Discovery of Drugs and Vaccines: an Update|1|9|ChikakoSaotome{SAOTOMECHIKAKO}____DavidE.Benson{BENSONDAVIDE.}|JonathanJ.Jensen{JENSENJONATHANJ.}|SaraE.Dodson{DODSONSARAE.}|MarkL.Rohrbaugh{ROHRBAUGHMARKL.}

S24

Cutting Edge Lecture 16
The ...

09:25

SumikoMochida{MOCHIDASUMIKO}|GeraldW.Zamponi{ZAMPONIGERALDW.}|MakotoTominaga{TOMINAGAMAKOTO}|AnnetteC.Dolphin{DOLPHINANNETTEC.}____Symposium 19
Ca2+ signaling in health and disease|1|3|GaryStephens{STEPHENSGARY}|SumikoMochida{MOCHIDASUMIKO}____YasunoriTakayama{TAKAYAMAYASUNORI}|SandraDerouiche{DEROUICHESANDRA}

S63

Symposium 19
Ca2+ signaling in health and disease

15:10

DavidR.Sibley{SIBLEYDAVIDR.}|AmyH.Newman{NEWMANAMYH.}|RobLane{LANEROB}|BryanL.Roth{ROTHBRYANL.}____Symposium 20
Recent advances in the development of subtype-selective and signaling-biased drugs for D2-like dopamine receptors: Towards improved therapeutics for neuropsychiatric disorders|1|3|DavidR.Sibley{SIBLEYDAVIDR.}|AmyH.Newman{NEWMANAMYH.}____MartaSanchezSoto{SANCHEZSOTOMARTA}|BlairK.A.Willette{WILLETTEBLAIRK.A.}|ElizabethC.Gonye{GONYEELIZABETHC.}|AnnahM.Moore{MOOREANNAHM.}|AmyE.Moritz{MORITZAMYE.}|RaviKumarVerma{KUMARVERMARAVI}|HideakiYano{YANOHIDEAKI}|LeiShi{SHILEI}|RBenjaminFree{FREERBENJAMIN}|Zhi-BingYou{YOUZHI-BING}|Guo-HuaBi{BIGUO-HUA}|VivekKumar{KUMARVIVEK}|AnverShaik{SHAIKANVER}|EliotGardner{GARDNERELIOT}|Zheng-XiongXi{XIZHENG-XIONG}

S64

Symposium 20
Recent advances in the development of subtype-selec...

09:25

Ho-YoungLee{LEEHO-YOUNG}|KeigoMachida{MACHIDAKEIGO}|Mi-KyoungKwak{KWAKMI-KYOUNG}|HozumiMotohashi{MOTOHASHIHOZUMI}____Symposium 21
Cancer Drug Resistance|1|14|SangGeonKim{KIMSANGGEON}|HoiYoungLee{LEEHOIYOUNG}____MengmeiZheng{ZHENGMENGMEI}|HifzurSiddique{SIDDIQUEHIFZUR}|PelegWiner{WINERPELEG}|AhmedRokan{ROKANAHMED}|VasuPunj{PUNJVASU}|LindaSher{SHERLINDA}|StanleyMTahara{TAHARASTANLEYM}|ChengyuLiang{LIANGCHENGYU}|HidekazuTsukamoto{TSUKAMOTOHIDEKAZU}|In-GeunRyoo{RYOOIN-GEUN}|DonghyeokKim{KIMDONGHYEOK}

S65

Symposium 21
Cancer Drug Resistance

15:10

HiroyoshiNishikawa{NISHIKAWAHIROYOSHI}|Woong-YangPark{PARKWOONG-YANG}|SeishiOgawa{OGAWASEISHI}|SimonA.Joosse{JOOSSESIMONA.}____Symposium 22
Novel targets and biomarkers for Anticancer Therapeutics|1|14|AtsushiOhtsu{OHTSUATSUSHI}|Woong-YangPark{PARKWOONG-YANG}____JinhoPark{PARKJINHO}

S66

Symposium 22
Novel targets and biomarkers for Anticancer Therape...

09:25

JohnL.Szarek{SZAREKJOHNL.}|ItsukoIshii{ISHIIITSUKO}|CarloBressa{BRESSACARLO}____Symposium 23
IPE: Educating a New Generation of Healthcare Professionals to Prescribe Medications Safely and Effectively|1|11|JayneS.Reuben{REUBENJAYNES.}____MasatoOkubo{OKUBOMASATO}|IkukoSakai{SAKAIIKUKO}|MariaOlgaCastelaoNaval{CASTELAONAVALMARIAOLGA}|OscarOlivaFernandez{OLIVAFERNANDEZOSCAR}|CarmenDiazCenteno{DIAZCENTENOCARMEN}|MariaTeresaCoirasLopez{COIRASLOPEZMARIATERESA}|OlgaGrecianoGreciano{GRECIANOGRECIANOOLGA}|MariaJosefaGutierrezCisneros{GUTIERREZCISNEROSMARIAJOSEFA}|PedroGargantillaMadera{GARGANTILLAMADERAPEDRO}|FranciscoJoseFarfanSedano{FARFANSEDANOFRANCISCOJOSE}|EvaMariaIcaranFrancisco{ICARANFRANCISCOEVAMARIA}

S67

Symposium 23
IPE: Educating a New Generation of Healthcare Profe...

15:10

CollenMasimirembwa{MASIMIREMBWACOLLEN}|TheresaA.John{JOHNTHERESAA.}|MichaelSpedding{SPEDDINGMICHAEL}|BernhardsOgutuRagama{RAGAMABERNHARDSOGUTU}____Symposium 24
Experiences and models for strengthening pharmacological research, teaching and services in resource strained countries|1|11|CollenMasimirembwa{MASIMIREMBWACOLLEN}|MichaelSpedding{SPEDDINGMICHAEL}____

S68

Symposium 24
Experiences and models for strengthening pharmacolo...

09:25

StevenH.DeVries{DEVRIESSTEVENH.}|TakahisaFurukawa{FURUKAWATAKAHISA}|HardyT.S.Kagimoto{KAGIMOTOHARDYT.S.}|MasayoTakahashi{TAKAHASHIMASAYO}____Symposium 25
Frontiers in approaching retinal research -The current status and future in development of therapeutic strategies based on genetic and iPS methods-|1|15|HideakiHara{HARAHIDEAKI}|HardyT.S.Kagimoto{KAGIMOTOHARDYT.S.}____TaroChaya{CHAYATARO}|RyotaroTsutsumi{TSUTSUMIRYOTARO}

S69

Symposium 25
Frontiers in approaching retinal research -The curr...

15:10

DavidJ.Webb{WEBBDAVIDJ.}|AnnaY.Zecharia{ZECHARIAANNAY.}|MelisaWallace{WALLACEMELISA}|StephenJ.Hill{HILLSTEPHENJ.}____Symposium 26
The BPS Focus on Pharmacology Project: Securing the future of Pharmacology & Clinical Pharmacology|1|9|DavidJ.Webb{WEBBDAVIDJ.}|StephenJ.Hill{HILLSTEPHENJ.}____

S70

Symposium 26
The BPS Focus on Pharmacology Project: Securing the...

09:25

ChristopherSouthan{SOUTHANCHRISTOPHER}|DavidE.Gloriam{GLORIAMDAVIDE.}|KozoKaibuchi{KAIBUCHIKOZO}|BryanL.Roth{ROTHBRYANL.}____Symposium 27
Computational Pharmacology, Databases and Drug Discovery|1|9|DavidE.Gloriam{GLORIAMDAVIDE.}|AdamPawson{PAWSONADAM}____ElenaFaccenda{FACCENDAELENA}|JoannaLSharman{SHARMANJOANNAL}|SimonDHarding{HARDINGSIMOND}|AdamJPawson{PAWSONADAMJ}|JamieADavies{DAVIESJAMIEA}|MutsukiAmano{AMANOMUTSUKI}|TakakiNishioka{NISHIOKATAKAKI}|JunichiroYoshimoto{YOSHIMOTOJUNICHIRO}

S71

Symposium 27
Computational Pharmacology, Databases and Drug Disc...

15:10

Nam-JoonCho{CHONAM-JOON}|GlauciusOliva{OLIVAGLAUCIUS}|TimothyN.Wells{WELLSTIMOTHYN.}____Symposium 28
New Drugs for Emerging Infectious Disease|1|17|MauroM.Teixeira{TEIXEIRAMAUROM.}|TimothyN.Wells{WELLSTIMOTHYN.}____AndreS.Godoy{GODOYANDRES.}|KetlynI.Z..Oliveira{OLIVEIRAKETLYNI.Z..}|NathalyaC.M.R.Mesquita{MESQUITANATHALYAC.M.R.}|GustavoM.A.Lima{LIMAGUSTAVOM.A.}|RafaelV.C.Guido{GUIDORAFAELV.C.}|PaulAWillis{WILLISPAULA}|JeremyNBurrows{BURROWSJEREMYN}

S72

Symposium 28
New Drugs for Emerging Infectious Disease

09:25

DouglasW.Oliver{OLIVERDOUGLASW.}|FaithApolotOkalebo{OKALEBOFAITHAPOLOT}|MohamedT.Khayyal{KHAYYALMOHAMEDT.}|AlexanderNiiOtoDodoo{DODOOALEXANDERNIIOTO}____Symposium 29
Pharmacology for Africa Symposium - African Indigenous Biodiversity: Gateway for Discovery|1|1|DouglasW.Oliver{OLIVERDOUGLASW.}|OmotayoO.Ebong{EBONGOMOTAYOO.}____MakhotsoLekhooa{LEKHOOAMAKHOTSO}|AnastasiaNkathaGuantai{GUANTAIANASTASIANKATHA}

S73

Symposium 29
Pharmacology for Africa Symposium - African Indigen...

15:10

Shin'ichiTakeda{TAKEDASHIN'ICHI}|PimPijnappel{PIJNAPPELPIM}|MasatoshiHagiwara{HAGIWARAMASATOSHI}|AdrianR.Krainer{KRAINERADRIANR.}____Symposium 30
Therapeutic manipulation of RNA/DNA for genetic diseases|1|18|MasatoshiHagiwara{HAGIWARAMASATOSHI}|AdrianR.Krainer{KRAINERADRIANR.}____ErikVanDerWal{VANDERWALERIK}|AtzeBergsma{BERGSMAATZE}|HolmZaehres{ZAEHRESHOLM}|HansRScholer{SCHOLERHANSR}|AnsTVanDerPloeg{VANDERPLOEGANST}|MarcosJArauzo-Bravo{ARAUZO-BRAVOMARCOSJ}

S74

Symposium 30
Therapeutic manipulation of RNA/DNA for genetic dis...

09:25

YuichiSugiyama{SUGIYAMAYUICHI}|KyungsooPark{PARKKYUNGSOO}|RyoseiKawai{KAWAIRYOSEI}____Symposium 31
Horizon of PMx|1|16|KojiChiba{CHIBAKOJI}|Dong-SeokYim{YIMDONG-SEOK}____DongwooChae{CHAEDONGWOO}|ChungMoNam{NAMCHUNGMO}|JooHoonKim{KIMJOOHOON}|SunYoungRha{RHASUNYOUNG}

S75

Symposium 31
Horizon of PMx

09:25

HirokiR.Ueda{UEDAHIROKIR.}|Hans-UlrichDodt{DODTHANS-ULRICH}|RobertE.Campbell{CAMPBELLROBERTE.}|TakeharuNagai{NAGAITAKEHARU}____Symposium 32
Understanding living systems by extensive analyses of all cells|1|10|HirokiR.Ueda{UEDAHIROKIR.}|TakeharuNagai{NAGAITAKEHARU}____SaiedehSaghafi{SAGHAFISAIEDEH}|KlausBecker{BECKERKLAUS}|ChristianHahn{HAHNCHRISTIAN}|MarkoPende{PENDEMARKO}|InnaSabdyusheva-Litschauer{SABDYUSHEVA-LITSCHAUERINNA}|MassihForoughipour{FOROUGHIPOURMASSIH}|IsratFarhana{FARHANAISRAT}|KazushiSuzuki{SUZUKIKAZUSHI}|TomokiMatsuda{MATSUDATOMOKI}

S76

Symposium 32
Understanding living systems by extensive analyses ...

15:10

RoyWollman{WOLLMANROY}|JaeKyoungKim{KIMJAEKYOUNG}|ShinyaKuroda{KURODASHINYA}|MarikoOkada{OKADAMARIKO}____Symposium 33
Systems Biology and Drug Targeting|1|10|ShinyaKuroda{KURODASHINYA}|RoyWollman{WOLLMANROY}____

S77

Symposium 33
Systems Biology and Drug Targeting

09:25

MasahiroTohkin{TOHKINMASAHIRO}|YoshiakiUyama{UYAMAYOSHIAKI}|IngerMollerup{MOLLERUPINGER}|In-JinJang{JANGIN-JIN}____Symposium 34
Global clinical trials and ethnic factors|1|6|MasahiroTohkin{TOHKINMASAHIRO}|In-JinJang{JANGIN-JIN}____YuKyongKim{KIMYUKYONG}|SeungHwanLee{LEESEUNGHWAN}

S78

Symposium 34
Global clinical trials and ethnic factors

15:10

CatherineTuleu{TULEUCATHERINE}|TsuyoshiFukuda{FUKUDATSUYOSHI}|SaraVanDriest{VANDRIESTSARA}____Symposium 35
Innovative approach to pediatric drug development and clinical practice(Topics include pharmacogenomics, pharmacometrics and new formulations.)|1|12|HidefumiNakamura{NAKAMURAHIDEFUMI}|WeiZhao{ZHAOWEI}____

S79

Symposium 35
Innovative approach to pediatric drug development a...

12:30

MakotoTsuda{TSUDAMAKOTO}____JPS Frontiers Session 2
Modulation of somatosensory information processing in the spinal cord by glial cells|Toray Industries, Inc.|1|1|YasuhitoUezono{UEZONOYASUHITO}____

K5

JPS Frontiers Session 2
Modulation of ...

Sponsor:Toray Industries, Inc.

12:30

YujiIkegaya{IKEGAYAYUJI}____JPS Frontiers Session 3
Mesoscopic approaches for the function of neuronal networks and pharmacological insights|1|1|YoshioGoshima{GOSHIMAYOSHIO}____

K2

JPS Frontiers Session 3
Mesoscopic app...

12:30

TappeiTakada{TAKADATAPPEI}____JSCPT Frontiers Session 2
Reverse translational research on membrane transporters|1|1|NaokiMatsumoto{MATSUMOTONAOKI}____

K7

JSCPT Frontiers Session 2
Reverse tran...

12:30

HiroyoshiNishikawa{NISHIKAWAHIROYOSHI}____Luncheon Seminar 5
Translational research of targeting T cell for Immuno-oncology (I-O) therapy|Bristol Myers Squib K.K.|1|1|YuichiAndo{ANDOYUICHI}____

LS5

Luncheon Seminar 5
Translational resea...

Sponsor:Bristol Myers Squib K.K.

12:30

TomoyukiFuruyashiki{FURUYASHIKITOMOYUKI}____Luncheon Seminar 6
The expanding role of prostaglandins in the brain: from sickness symptoms to stress-related behaviors|ONO PHARMACEUTICAL CO., LTD.|1|1|YukihikoSugimoto{SUGIMOTOYUKIHIKO}____

LS6

Luncheon Seminar 6
The expanding role ...

Sponsor:ONO PHARMACEUTICAL CO., LTD.

12:30

-____JSCPT Session (Japanese)|Chugai Pharmaceutical Co., Ltd.|1|1|-____

LS7

JSCPT Session (Japanese)

Sponsor:Chugai Pharmaceutical Co., Ltd.

12:30

TetsuzoTauchi{TAUCHITETSUZO}____Luncheon Seminar 8
Translational Research in an Era of Targeted Therapy|Pfizer Japan Inc.|1|1|-____

LS8

Luncheon Seminar 8
Translational Resea...

Sponsor:Pfizer Japan Inc.

13:50

YuOhmura{OHMURAYU}|JyrkiPKukkonen{KUKKONENJYRKIP}|ChieSakanaka{SAKANAKACHIE}|NigelH.Greig{GREIGH.NIGEL}|AjayPrakash{PRAKASHAJAY}____Oral session 6
Neuroscience 3: Affective disorders and Neurodegenerative disorders|1|1|NigelH.Greig{GREIGH.NIGEL}____KenjiFTanaka{TANAKAKENJIF}|AkihiroYamanaka{YAMANAKAAKIHIRO}|MitsuhiroYoshioka{YOSHIOKAMITSUHIRO}|MaijuKRinne{RINNEMAIJUK}|TeppoOLeino{LEINOTEPPOO}|AinoleenaTurku{TURKUAINOLEENA}|PauliMTurunen{TURUNENPAULIM}|YanaSteynen{STEYNENYANA}|HenriXhaard{XHAARDHENRI}|ErikAWallen{WALLENERIKA}|RyokoIhara{IHARARYOKO}|AkikoKishi{KISHIAKIKO}|KenjiKirihara{KIRIHARAKENJI}|GakuOguri{OGURIGAKU}|MihokoShibuya{SHIBUYAMIHOKO}|KazushiSuzuki{SUZUKIKAZUSHI}|KeikoUeda{UEDAKEIKO}|YumiUmeda-Kameyama{UMEDA-KAMEYAMAYUMI}|MitsutakaYakabe{YAKABEMITSUTAKA}|TomohiroHaga{HAGATOMOHIRO}|HidenoriYamasue{YAMASUEHIDENORI}|DavidTweedie{TWEEDIEDAVID}|YazhouLi{LIYAZHOU}|DanielaLecca{LECCADANIELA}|BarryJHoffer{HOFFERBARRYJ}|YunWang{WANGYUN}|MiaadBader{BADERMIAAD}|ChaimGPick{PICKCHAIMG}|Dong-SeokKim{KIMDONG-SEOK}|KanwaljeetChopra{CHOPRAKANWALJEET}|BikashMedhi{MEDHIBIKASH}

O6

Oral session 6
Neuroscience 3: Affecti...

13:50

RobinPlevin{PLEVINROBIN}|EijiroNakamura{NAKAMURAEIJIRO}|ReikoSugiura{SUGIURAREIKO}|HongshengWang{WANGHONGSHENG}____Oral session 7
Cancer 1|1|1|ReikoSugiura{SUGIURAREIKO}|RobinPlevin{PLEVINROBIN}____AhlamAl-Obaidi{AL-OBAIDIAHLAM}|YousifKhalaf{KHALAFYOUSIF}|SimonMackay{MACKAYSIMON}|AndrewPaul{PAULANDREW}

O7

Oral session 7
Cancer 1

13:50

JamieJColeman{COLEMANJAMIEJ}|JaranEriksen{ERIKSENJARAN}|YuheiNishimura{NISHIMURAYUHEI}|OlabodeOEkerin{EKERINOLABODEO}____Oral session 8
Education and Training|1|1|SimonMaxwell{MAXWELLSIMON}|HirotoshiEchizen{ECHIZENHIROTOSHI}____SarahKPontefract{PONTEFRACTSARAHK}|HannahKVallance{VALLANCEHANNAHK}|NicCBlackwell{BLACKWELLNICC}|ElizabethAHughes{HUGHESELIZABETHA}|RobinEFerner{FERNERROBINE}|JulieMason{MASONJULIE}|JohnJMarriott{MARRIOTTJOHNJ}|LarsLGustafsson{GUSTAFSSONLARSL}|KristinaAteva{ATEVAKRISTINA}|PiaBastholm-Rahmner{BASTHOLM-RAHMNERPIA}|Marie-LouiseOvesjoe{OVESJOEMARIE-LOUISE}|MariaJuhasz-Haverinen{JUHASZ-HAVERINENMARIA}|GerdLaerfars{LAERFARSGERD}|RickardEMalmstroem{MALMSTROEMRICKARDE}|BjornWettermark{WETTERMARKBJORN}|EvaAndersen-Karlsson{ANDERSEN-KARLSSONEVA}|ShikoOkabe{OKABESHIKO}|MizukiYuge{YUGEMIZUKI}|TomokoTada{TADATOMOKO}|YumiSato{SATOYUMI}|TheresaAJohn{JOHNTHERESAA}

O8

Oral session 8
Education and Training

13:50

FarjanaAkther{AKTHERFARJANA}|MarinaMakrecka-Kuka{MAKRECKA-KUKAMARINA}|WenbinShang{SHANGWENBIN}|LauraPiqueras{PIQUERASLAURA}|MinGao{GAOMIN}____Oral session 9
Metabolism and Diabetes 1|1|1|WenbinShang{SHANGWENBIN}|FarjanaAkther{AKTHERFARJANA}____MdRahatullahRazan{RAZANMDRAHATULLAH}|JamesL.Graham{GRAHAMJAMESL.}|KimberL.Stanhope{STANHOPEKIMBERL.}|PeterJ.Havel{HAVELPETERJ.}|RosahnakRahimian{RAHIMIANROSAHNAK}|JanisKuka{KUKAJANIS}|ReinisVilskersts{VILSKERSTSREINIS}|ElinaMakarova{MAKAROVAELINA}|MaijaDambrova{DAMBROVAMAIJA}|EdgarsLiepinsh{LIEPINSHEDGARS}|LiWang{WANGLI}|Jiang-YunLuo{LUOJIANG-YUN}|XiaoYuTian{TIANXIAOYU}|YuHuang{HUANGYU}|LuisaHueso{HUESOLUISA}|RebecaOrtega{ORTEGAREBECA}|BlancaAlabadi{ALABADIBLANCA}|MiguelCivera{CIVERAMIGUEL}|MariaJesusSanz{SANZMARIAJESUS}|JuanFAscaso{ASCASOJUANF}|JoseTReal{REALJOSET}|JingwenXie{XIEJINGWEN}|JingXue{XUEJING}|YitingWang{WANGYITING}|LiQin{QINLI}|XiaoyanLi{LIXIAOYAN}

O9

Oral session 9
Metabolism and Diabetes 1

13:50

GillianCasey{CASEYGILLIAN}|PierreThibeault{THIBEAULTPIERRE}|TaniaRomacho{ROMACHOTANIA}|DhiteBNugroho{NUGROHODHITEB}|ReikoSakaguchi{SAKAGUCHIREIKO}____Oral session 10
Cardiovascular System 3: Vessel/Endothelium/Atherosclerosis|1|1|KatsuyaHirano{HIRANOKATSUYA}|StefanOffermanns{OFFERMANNSSTEFAN}____PaulSpiers{SPIERSPAUL}|JordanCLesarge{LESARGEJORDANC}|ArendsD'Arcy{ARENDSD'ARCY}|MichaelaFernandes{FERNANDESMICHAELA}|LenLuyt{LUYTLEN}|RithwikRamachandran{RAMACHANDRANRITHWIK}|MariellaRamos-Gonzalez{RAMOS-GONZALEZMARIELLA}|SusanaVallejo{VALLEJOSUSANA}|FernandoRivilla{RIVILLAFERNANDO}|ConcepcionPeiro{PEIROCONCEPCION}|CarlosFSanchez-Ferrer{SANCHEZ-FERRERCARLOSF}|KojiIkeda{IKEDAKOJI}|AgianJBarinda{BARINDAAGIANJ}|DonytraAWardhana{WARDHANADONYTRAA}|KeikoYagi{YAGIKEIKO}|Ken-IchiHirata{HIRATAKEN-ICHI}|NoriakiEmoto{EMOTONORIAKI}|NobuakiTakahashi{TAKAHASHINOBUAKI}|TakashiYoshida{YOSHIDATAKASHI}|ShinichiroYamamoto{YAMAMOTOSHINICHIRO}|YujiHara{HARAYUJI}|MasayukiXMori{MORIMASAYUKIX}|TetsushiFurukawa{FURUKAWATETSUSHI}|ShunichiShimizu{SHIMIZUSHUNICHI}|RyujiInoue{INOUERYUJI}|YasuoMori{MORIYASUO}

O10

Oral session 10
Cardiovascular System ...

13:50

ClaudiaCavadas{CAVADASCLAUDIA}|JaeseongOh{OHJAESEONG}|ReoTanoshima{TANOSHIMAREO}|LingyueMa{MALINGYUE}____Oral session 11
Rare Diseases/Genomics/Pharmacogenomics/Personalized Medicine|1|1|IchiroIeiri{IEIRIICHIRO}|In-JinJang{JANGIN-JIN}____MarisaFerreira-Marques{FERREIRA-MARQUESMARISA}|LuisaCortes{CORTESLUISA}|JorgeValero{VALEROJORGE}|DinaPereira{PEREIRADINA}|LuisPereiradeAlmeida{PEREIRADEALMEIDALUIS}|CeliaAAveleira{AVELEIRACELIAA}|Yong-WonShin{SHINYONG-WON}|JangsupMoon{MOONJANGSUP}|JihoonG.Yoon{YOONJIHOONG.}|SungkyoungChoi{CHOISUNGKYOUNG}|YunKim{KIMYUN}|KonChu{CHUKON}|SangKunLee{LEESANGKUN}|MinGooLee{LEEMINGOO}|In-JinJang{JANGIN-JIN}|AmnaKhan{KHANAMNA}|AgnieszkaKBiala{BIALAAGNIESZKAK}|JessicaNTrueman{TRUEMANJESSICAN}|BrittIDrogemoller{DROGEMOLLERBRITTI}|GalenEbWright{WRIGHTGALENEB}|GabriellaSsGroeneweg{GROENEWEGGABRIELLASS}|ColinJdRoss{ROSSCOLINJD}|BruceCCarleton{CARLETONBRUCEC}|NanZhao{ZHAONAN}|QianXiang{XIANGQIAN}|XiaZhao{ZHAOXIA}|PinglanLiu{LIUPINGLAN}|YingZhou{ZHOUYING}|YiminCui{CUIYIMIN}

O11

Oral session 11
Rare Diseases/Genomics...

13:50

Ling-YeaYu{YULING-YEA}|MingXue{XUEMING}|TomoyukiMiyazaki{MIYAZAKITOMOYUKI}|KazunoriKanemaru{KANEMARUKAZUNORI}|TaichiroTomida{TOMIDATAICHIRO}____Oral session 12
Systems Biology/Molecular Bioimaging|1|1|KojiL.Ode{ODEKOJIL.}____Ting-JenTseng{TSENGTING-JEN}|Yung-JenXiao{XIAOYUNG-JEN}|Chia-JungTsai{TSAICHIA-JUNG}|Hsuan-ChaoLin{LINHSUAN-CHAO}|Feng-ChiaoTsai{TSAIFENG-CHIAO}|BinbinXia{XIABINBIN}|TaoZhou{ZHOUTAO}|CanCui{CUICAN}|HaitingCheng{CHENGHAITING}|MingmingWang{WANGMINGMING}|SuSu{SUSU}|YiMa{MAYI}|JingyiLi{LIJINGYI}|ZhengchaoXia{XIAZHENGCHAO}|WakiNakajima{NAKAJIMAWAKI}|TetsuArisawa{ARISAWATETSU}|MaiHatano{HATANOMAI}|TakuyaTakahashi{TAKAHASHITAKUYA}|IsamuTaiko{TAIKOISAMU}|NamiKitajima{KITAJIMANAMI}|HiroshiSekiya{SEKIYAHIROSHI}|MasamitsuIino{IINOMASAMITSU}|KimitakaYamaguchi{YAMAGUCHIKIMITAKA}|MasanoriIto{ITOMASANORI}|ShingoMurakami{MURAKAMISHINGO}|YoshinoriMikami{MIKAMIYOSHINORI}|SatomiAdachi-Akahane{ADACHI-AKAHANESATOMI}

O12

Oral session 12
Systems Biology/Molecu...

13:50

KotoneMatsuyama{MATSUYAMAKOTONE}|VenturaASimonovich{SIMONOVICHVENTURAA}|JaykaranCharan{CHARANJAYKARAN}|YusukeEndo{ENDOYUSUKE}|MuSeongBan{BANMUSEONG}____Oral session 13
Clinical Drug Development|1|1|KinweiArnoldChan{CHANKINWEIARNOLD}|BhagirathK.Patel{PATELBHAGIRATHK.}____KoujiIwasaki{IWASAKIKOUJI}|NoriakiNagao{NAGAONORIAKI}|YukikoMatsushima{MATSUSHIMAYUKIKO}|HiroshiHayashi{HAYASHIHIROSHI}|ShojiSanada{SANADASHOJI}|YukiSuzaki{SUZAKIYUKI}|GoshiOzawa{OZAWAGOSHI}|TakuhiroYamaguchi{YAMAGUCHITAKUHIRO}|NaotoUemura{UEMURANAOTO}|CintiaVCruz{CRUZCINTIAV}|MarianaGFernandez{FERNANDEZMARIANAG}|PaulaScibona{SCIBONAPAULA}|ValeriaBeruto{BERUTOVALERIA}|WaldoHBelloso{BELLOSOWALDOH}|JatinVDhanani{DHANANIJATINV}|MaulikSDoshi{DOSHIMAULIKS}|TeaReljic{RELJICTEA}|AthanasiosTsalatsanis{TSALATSANISATHANASIOS}|AmbujKumar{KUMARAMBUJ}|ChikaYamamoto{YAMAMOTOCHIKA}|HiroshiSunada{SUNADAHIROSHI}|MikiShimada{SHIMADAMIKI}|AtsushiTakenaka{TAKENAKAATSUSHI}|JunGiHwang{HWANGJUNGI}|JaeHoonShim{SHIMJAEHOON}|AnhyeKim{KIMANHYE}|Joo-YounCho{CHOJOO-YOUN}|HowardLee{LEEHOWARD}

O13

Oral session 13
Clinical Drug Development

09:25

-____JSCPT Session (Japanese)|1|1|-____

TABLE019

JSCPT Session (Japanese)

15:10

-____JSCPT Session (Japanese)|1|1|-____

TABLE024

JSCPT Session (Japanese)

13:30

-____Pharmacology for Africa General Assembly|1|1|-____

TABLE050

Pharmacology for Africa General Assembly

Advanced Search